Sinopharm Group Future Growth
Future criteria checks 1/6
Sinopharm Group is forecast to grow earnings and revenue by 4.5% and 5.8% per annum respectively. EPS is expected to grow by 4.6% per annum. Return on equity is forecast to be 7.7% in 3 years.
Key information
4.5%
Earnings growth rate
4.6%
EPS growth rate
Healthcare earnings growth | 20.9% |
Revenue growth rate | 5.8% |
Future return on equity | 7.7% |
Analyst coverage | Good |
Last updated | 31 Oct 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 698,276 | 10,026 | 12,706 | 13,062 | 14 |
12/31/2025 | 650,544 | 9,223 | 12,286 | 12,432 | 16 |
12/31/2024 | 599,101 | 8,174 | 21,344 | 15,575 | 12 |
6/30/2024 | 590,346 | 8,653 | 16,768 | 19,506 | N/A |
3/31/2024 | 598,415 | 9,315 | 34,844 | 37,370 | N/A |
12/31/2023 | 596,570 | 9,054 | 14,889 | 17,173 | N/A |
9/30/2023 | 594,526 | 9,248 | 36,909 | 39,315 | N/A |
6/30/2023 | 591,626 | 8,936 | 9,660 | 11,931 | N/A |
3/31/2023 | 570,067 | 8,688 | 14,302 | 16,763 | N/A |
12/31/2022 | 552,148 | 8,526 | 18,648 | 20,964 | N/A |
9/30/2022 | 546,147 | 7,914 | 6,159 | 8,507 | N/A |
6/30/2022 | 533,403 | 7,870 | 492 | 2,783 | N/A |
3/31/2022 | 528,383 | 7,970 | 5,378 | 7,658 | N/A |
12/31/2021 | 521,051 | 7,759 | 7,081 | 9,308 | N/A |
9/30/2021 | 507,611 | 7,847 | -13,311 | -11,252 | N/A |
6/30/2021 | 501,770 | 7,874 | 8,743 | 10,983 | N/A |
3/31/2021 | 474,798 | 6,956 | -12,001 | -9,890 | N/A |
12/31/2020 | 456,415 | 7,187 | 9,099 | 11,155 | N/A |
9/30/2020 | 442,674 | 6,698 | 23,821 | 26,121 | N/A |
6/30/2020 | 427,372 | 6,174 | 2,304 | 4,522 | N/A |
3/31/2020 | 431,976 | 6,554 | 24,344 | 26,653 | N/A |
12/31/2019 | 425,273 | 6,251 | 16,417 | 18,777 | N/A |
9/30/2019 | 406,394 | 6,311 | -5 | 2,113 | N/A |
6/30/2019 | 382,717 | 6,012 | -224 | 1,744 | N/A |
3/31/2019 | 360,760 | 6,087 | -5,010 | -3,011 | N/A |
12/31/2018 | 344,526 | 5,834 | 392 | 3,654 | N/A |
9/30/2018 | 336,113 | 5,523 | -9,906 | -6,868 | N/A |
6/30/2018 | 334,060 | 5,606 | -170 | 2,882 | N/A |
3/31/2018 | 318,414 | 5,083 | N/A | -6,249 | N/A |
12/31/2017 | 308,354 | 5,572 | N/A | 3,209 | N/A |
9/30/2017 | 288,855 | 5,217 | N/A | -19 | N/A |
6/30/2017 | 269,356 | 4,861 | N/A | -3,247 | N/A |
3/31/2017 | 264,691 | 4,996 | N/A | N/A | N/A |
12/31/2016 | 258,388 | 4,635 | N/A | 9,258 | N/A |
9/30/2016 | 251,401 | 4,515 | N/A | 11,117 | N/A |
6/30/2016 | 244,414 | 4,394 | N/A | 12,975 | N/A |
3/31/2016 | 234,499 | 3,885 | N/A | N/A | N/A |
12/31/2015 | 228,673 | 3,772 | N/A | 13,412 | N/A |
9/30/2015 | 222,513 | 3,548 | N/A | 9,472 | N/A |
6/30/2015 | 216,353 | 3,323 | N/A | 5,533 | N/A |
3/31/2015 | 207,865 | 3,037 | N/A | N/A | N/A |
12/31/2014 | 200,131 | 2,875 | N/A | 5,561 | N/A |
9/30/2014 | 190,883 | 2,719 | N/A | 5,747 | N/A |
6/30/2014 | 181,635 | 2,564 | N/A | 5,933 | N/A |
3/31/2014 | 174,251 | 2,407 | N/A | 5,437 | N/A |
12/31/2013 | 166,866 | 2,250 | N/A | 4,941 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SHTD.F's forecast earnings growth (4.5% per year) is above the savings rate (2.6%).
Earnings vs Market: SHTD.F's earnings (4.5% per year) are forecast to grow slower than the US market (15.4% per year).
High Growth Earnings: SHTD.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: SHTD.F's revenue (5.8% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: SHTD.F's revenue (5.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SHTD.F's Return on Equity is forecast to be low in 3 years time (7.7%).